E. A. McKie

983 total citations
8 papers, 799 citations indexed

About

E. A. McKie is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, E. A. McKie has authored 8 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in E. A. McKie's work include Herpesvirus Infections and Treatments (7 papers), Virus-based gene therapy research (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). E. A. McKie is often cited by papers focused on Herpesvirus Infections and Treatments (7 papers), Virus-based gene therapy research (4 papers) and Toxin Mechanisms and Immunotoxins (3 papers). E. A. McKie collaborates with scholars based in United Kingdom, Slovakia and New Zealand. E. A. McKie's co-authors include J. Harland, G. Cruickshank, R Rampling, James A. R. Nicoll, Richard Petty, M. Brown, Andrew G. MacLean, D. Brennan, Donald M. Hadley and Vakis Papanastassiou and has published in prestigious journals such as Journal of Virology, British Journal of Cancer and Journal of General Virology.

In The Last Decade

E. A. McKie

8 papers receiving 770 citations

Peers

E. A. McKie

GENET

EPIDE

MB

ONCOL

IMMUN

Daniel Öberg Sweden

M P Quinlan United States

Nicola Philpott United States

Elisabetta Sporeno Italy

Markus Hörer Germany

Katsunori Shinozaki United States

Johanna K. Kaufmann Germany

Robert C. Münch Germany

Anna Zingale Italy

Michael K. Bamat United States

Daniel Öberg Sweden

E. A. McKie

273 ×0.4

GENET

190 ×0.5

EPIDE

374 ×1.0

MB

180 ×0.6

ONCOL

91 ×0.8

IMMUN

Citations per year, relative to E. A. McKie E. A. McKie (= 1×) peers Daniel Öberg

Countries citing papers authored by E. A. McKie

Since Specialization

Citations

This map shows the geographic impact of E. A. McKie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. McKie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. McKie more than expected).

Fields of papers citing papers by E. A. McKie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. A. McKie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. McKie. The network helps show where E. A. McKie may publish in the future.

Co-authorship network of co-authors of E. A. McKie

This figure shows the co-authorship network connecting the top 25 collaborators of E. A. McKie. A scholar is included among the top collaborators of E. A. McKie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. A. McKie. E. A. McKie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Rampling, R, G. Cruickshank, Vakis Papanastassiou, et al.. (2000). Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Therapy. 7(10). 859–866. 478 indexed citations

2.

McKie, E. A., et al.. (1998). Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector – potential glioblastoma targeting. Gene Therapy. 5(4). 440–450. 33 indexed citations

3.

Brown, Stuart M., Alasdair Maclean, E. A. McKie, & J. Harland. (1997). The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34. Journal of Virology. 71(12). 9442–9449. 77 indexed citations

4.

McKie, E. A., et al.. (1996). Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours - evaluation of a potentially effective clinical therapy. British Journal of Cancer. 74(5). 745–752. 94 indexed citations

5.

McKie, E. A., et al.. (1995). The transcripts from the sequences flanking the short component of Marek's disease virus during latent infection form a unique family of 3'-coterminal RNAs. Journal of Virology. 69(2). 1310–1314. 27 indexed citations

6.

Spivack, J G, Moin U. Fareed, Stephen J. O’Keefe, et al.. (1995). Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 34.5 mutants in a mouse eye model. Journal of General Virology. 76(2). 321–332. 33 indexed citations

7.

McKie, E. A., RM Hope, Stuart M. Brown, & Alasdair Maclean. (1994). Characterization of the herpes simplex virus type 1 strain 17+ neurovirulence gene RL1 and its expression in a bacterial system. Journal of General Virology. 75(4). 733–741. 19 indexed citations

8.

Dolan, Aidan, E. A. McKie, Alasdair Maclean, & Duncan J. McGeoch. (1992). Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17. Journal of General Virology. 73(4). 971–973. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact